EP4028771 - ASSAY [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 17.05.2024 Database last updated on 03.09.2024 | |
Former | Request for examination was made Status updated on 17.06.2022 | ||
Former | The international publication has been made Status updated on 19.03.2021 | ||
Former | unknown Status updated on 15.09.2020 | Most recent event Tooltip | 17.05.2024 | Withdrawal of application | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89 1330 Rixensart / BE | [2022/29] | Inventor(s) | 01 /
CHAPLET, Michael GlaxoSmithKline Biologicals SA Rue de l'Institut 89 1330 Rixensart / BE | 02 /
NORAIS, Nathalie GlaxoSmithKline Via Fiorentina 1 53100 Siena / IT | 03 /
RONDINI, Simona GlaxoSmithKline Via Fiorentina 1 53100 Siena / IT | 04 /
ROSSI PACCANI, Silvia GlaxoSmithKline Via Fiorentina 1 53100 Siena / IT | [2022/29] | Representative(s) | Broom, Ashley John GlaxoSmithKline 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2022/29] | Application number, filing date | 20767813.7 | 09.09.2020 | [2022/29] | WO2020EP75128 | Priority number, date | EP20190196718 | 11.09.2019 Original published format: EP 19196718 | [2022/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021048159 | Date: | 18.03.2021 | Language: | EN | [2021/11] | Type: | A1 Application with search report | No.: | EP4028771 | Date: | 20.07.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.03.2021 takes the place of the publication of the European patent application. | [2022/29] | Search report(s) | International search report - published on: | EP | 18.03.2021 | Classification | IPC: | G01N33/569 | [2022/29] | CPC: |
G01N33/56911 (EP,US);
C07K16/1203 (US);
C07K2317/33 (US);
G01N2333/212 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/29] | Title | German: | TEST | [2022/29] | English: | ASSAY | [2022/29] | French: | DOSAGE | [2022/29] | Entry into regional phase | 11.03.2022 | National basic fee paid | 11.03.2022 | Designation fee(s) paid | 11.03.2022 | Examination fee paid | Examination procedure | 11.03.2022 | Examination requested [2022/29] | 11.03.2022 | Date on which the examining division has become responsible | 21.10.2022 | Amendment by applicant (claims and/or description) | 13.05.2024 | Application withdrawn by applicant [2024/25] | Fees paid | Renewal fee | 21.09.2022 | Renewal fee patent year 03 | 20.09.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9828333 (UNIV TEXAS [US], et al) [X] 1-15 * chapter 5.0, pages 40 et seq.; examples *; | [T]WO2015125118 (GLAXOSMITHKLINE BIOLOG SA [BE]); | [T]WO2019170702 (GLAXOSMITHKLINE BIOLOGICALS SA [BE]) [T] * p16 first par;; claim 18; sequences 82,84 * | by applicant | WO2007018463 | WO2015125118 | - HOICZYK E et al., EMBO J., (20000000), vol. 19, no. 22, pages 5989 - 99 | - AEBI C et al., Infect Immun., (19970000), vol. 65, no. 11, pages 4367 - 77 | - HELMINEN ME et al., J Infect Dis, (19940000), vol. 170, no. 4, pages 867 - 72 | - COPE LD et al., JBacteriol, (19990000), vol. 181, no. 13, pages 4026 - 34 | - TAN TT et al., J Infect Dis, (20050000), vol. 192, no. 6, pages 1029 - 38 | - TAN TT et al., J Infect Dis, (20060000), vol. 194, no. 4, pages 493 - 7 | - ATTIA AS et al., Infect Immun, (20050000), vol. 73, no. 4, pages 2400 - 10 | - VRIES et al., Microbiol Mol Biol Rev, (20090000), vol. 73, no. 3, pages 389 - 406 | - SAPEY ESTOCKLEY RA, "COPD exacerbations . 2: aetiology", Thorax, (20060000), vol. 61, no. 3, pages 250 - 8, XP009126262 | - ERB-DOWNWARD JR et al., PLoS One, (20110000), vol. 6, no. 2, page e16384 | - WILKINSON TMA et al., Thorax, (20170000), vol. 72, no. 10, pages 919 - 27 | - SETHI S et al., N Engl J Med, (20020000), vol. 347, no. 7, pages 465 - 71 | - ALAMOUDI OS et al., Respirology, (20070000), vol. 12, no. 2, pages 283 - 7 | - BANDI V et al., FEMS Immunol Med Microbiol, (20030000), vol. 37, no. 1, pages 69 - 75 | - BEASLEY V et al., Int J Chron Obstruct Pulmon Dis, (20120000), vol. 7, pages 555 - 69 | - HOLLIGER PHUDSON PJ, "Engineered antibody fragments and the rise of single domains", Nat Biotechnol, (20050000), vol. 23, no. 9, doi:10.1038/nbt1142, pages 1126 - 36, XP008076746 DOI: http://dx.doi.org/10.1038/nbt1142 | - "EMBOSS: The European Molecular Biology Open Software Suite", Trends in Genetics, (20000000), vol. 16, no. 6, page 276,277 | - NEEDLEMAN, S. B.WUNSCH, C. D., J. Mol. Biol., (19700000), vol. 48, pages 443 - 453 | - BROOKS MJSEDILLO JLWAGNER NLAURENCE CAWANG WATTIA AS et al., "Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function", Infect Immun, (20080000), vol. 76, no. 11, pages 5330 - 40 | - COPE et al., J Bacteriol, (19990000), vol. 181, no. 13, pages 4026 - 34 | - BROOKS et al., Infect Immun, (20080000), vol. 76, no. 11, pages 5330 - 40 | - HILL DJWHITTLES CVIRJI M, PLoS One, (20120000), vol. 7, no. 9, page e45452 | - BOURNE S et al., "Acute exacerbation and respiratory infections in COPD (AERIS): protocol for a prospective, obervational cohort study", BMJ open, (20140000), vol. 4, no. 3, page e004546 | - "Rapid Development of Monoclonal Antibodies Using Repetitive Immunizations, Multiple Sites", ERIC P. DIXON., Cell Biology (Third Edition) A Laboratory Handbook, Academic Press, (20060000), vol. 1, pages 483 - 90 | - KWAKYOON et al., J Immunol Methods, (19960000), vol. 191, no. 1, pages 49 - 54 | - CABILLYRIGGS, Gene, (19850000), vol. 40, no. 1, pages 157 - 61 |